Bernardino J, Roux C, Almeida A, Vogt N, Gibaud A, Gerbault-Seureau M, Magdelenat H, Bourgeois C A, Malfoy B, Dutrillaux B
Institut Curie-CNRS, UMR 147, Paris, France.
Cancer Genet Cytogenet. 1997 Sep;97(2):83-9. doi: 10.1016/s0165-4608(96)00385-8.
The global DNA methylation status was investigated on a series of 59 breast cancers by Southern blotting, using methylation sensitive restriction enzymes. By comparison to control DNA, almost all tumor DNAs were found globally hypomethylated. However, the demethylation was variable from tumor to tumor. Compared to other biological parameters, the methylation did not correlate with chromosome alterations, steroid hormone receptor status, or histopathological grading. Tumors which appeared to be the most evolved for other parameters were only mildly hypomethylated, whereas tumors with strongly hypomethylated DNA corresponded to those with slight alterations of the other parameters. Thus, DNA hypomethylation is a consistent characteristic of breast cancer, but its variations may not correlate with tumor progression of most breast cancers.
利用甲基化敏感限制性内切酶,通过Southern印迹法对59例乳腺癌进行了全基因组DNA甲基化状态研究。与对照DNA相比,几乎所有肿瘤DNA均呈现全基因组低甲基化。然而,不同肿瘤之间的去甲基化程度存在差异。与其他生物学参数相比,甲基化与染色体改变、类固醇激素受体状态或组织病理学分级无关。在其他参数方面表现出最显著进展的肿瘤仅呈现轻度低甲基化,而DNA高度低甲基化的肿瘤则与其他参数仅有轻微改变的肿瘤相对应。因此,DNA低甲基化是乳腺癌的一个一致特征,但其变化可能与大多数乳腺癌的肿瘤进展无关。